StockWatch
·

INFO EDGE (INDIA) LTD. Q1 FY27 Results

NAUKRIQ1 FY27 Results
Filing
Result:Good· Market: UpOne-off gainMargin expansion

Beat/Miss: Beat · Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValueQ4 FY26Q1 FY26
Revenue880.75 Cr1.4%11.4%
Total Income1.1K Cr21.4%6.9%
Expenditure580.44 Cr1.3%2.9%
PBT628.21 Cr27.2%44.2%
Net Profit490.05 Cr35.2%42.9%
OPM54.10%7.64pp21.24pp
NPM45.67%9.69pp11.52pp
EPS6.8821.2%50.5%
View full financials

Revenue and billings beat street (+11.4%/+14.4% YoY) with genuine 652bps operating margin expansion in Recruitment, but adjusted PAT growth is only ~+2% once the ₹140cr exceptional-gain swing is stripped out, tempering an otherwise healthy quarter.

INFO EDGE (INDIA) LTD. · Q1 FY27 · THE VERDICT

AI Inflection Masks Hiring Volume Slowdown

Reported profit surged 42.9%, but ₹156 Cr—nearly one-third of PAT—came from portfolio gains, not core recruitment. The real question: can new products offset stalling hiring volumes, especially in a consultant segment growing at just 1%?

14 Aug 2026 · 6 min read
Reported PAT

₹490.1 Cr

+42.9% YoY

Standalone Operating Profit

₹334 Cr

~40% margin

Portfolio Income

~₹156 Cr

32% of reported PAT

On the headline it's a blowout—consolidated PAT up 43%. But peel back one layer. Of the ₹490 crore reported profit, roughly ₹156 crore came from portfolio mark-to-market gains on the company's ₹5,000 crore investment portfolio across 135 companies. Standalone operating profit—the actual franchise—was ₹334 crore. That's solid. But it's not the quarter the stock's day-1 pop of 6.08% suggested, nor the one management's guidance reflects.

Reported vs. organic: where the profit came from

Q1 FY27 PAT, ₹ Cr
0182.97365.94548.91490.1Reported156Portfolio income334Standalone ops
Portfolio mark-to-market gains account for 32% of reported PAT. Standalone operating profit is the organic business.

That standalone ₹334 crore translates to a 40% operating margin on standalone revenue of ₹824 crore, up 12% YoY. Billings grew 14% on a consolidated basis. Both solid. Both within prior guidance of 'double-digit to mid-teens growth.' The stock bounced 6.08% on day 1 (delivery 48.6%, a tight move) and held +5.87% by day 3, suggesting conviction. But the conviction rests on portfolio gains, not a step-change in how the core business is performing. That distinction matters.

Claims vs. what holds up

Management's key on-call claims graded against delivered numbers

Better quarter than FY26 with billings momentum

Billings 14% YoY; recruitment 17% headline, 15% normalized for timing. Prior FY26 quarters ranged 10–12%.

Supported

99acres moved close to break-even, validating turnaround

Operating PBT losses reduced 89% to ~₹2 Cr; revenue +17%; cost discipline clear. Validates guidance to turn cash-generative in FY27.

Supported

AI-Rex showing strong commercial traction with 400 customers

400 out of 4,000 free trials (10% conversion); July saw ~300 additional sales. ₹3,500 per-mandate pricing holding. One cycle post-launch; renewal unproven.

Supported, early-stage

Recruitment core improved with 17% billings growth

Headline 17%, normalized 15%. GCC +31% headline (15–17% normalized); premium +25–30%; but consultant +1%, mid-market soft.

Partial (headline masks segment pressure)

GCC segment outperformance at 31% growth

True, but includes 2.5% timing benefit from deferred renewals; normalized 15–17% growth.

Overstated as headline

What changed on this call

99acres inflection: Operating PBT losses fell from ₹17 crore (Q4 normalized) to ~₹2 crore—an 89% reduction. Revenue +17% with disciplined cost management. The path to cash-generativity in H2 FY27 is now credible. Recruitment stabilization: Billings at 15% normalized (vs. 10–12% prior quarters) shows the core holding ground despite hiring softness. But—critically—volume growth flagged as 'the real challenge.' Consultant billings grew only 1% YoY; mid-market hiring soft. Management called the macro hiring market very modest. AI-Rex launch: 400 customers by Q1 close; ~300+ in July alone. Early-stage but sales momentum accelerating. Talent Pulse expansion: 600+ paid customers on consumption-based pricing. Jobseeker inflection: Billings +35% (vs. 18–20% prior); paid conversion doubled to 2.6% of monthly actives. A genuine new monetization lever. Shiksha structural decline: Billings -23%, revenue -12%; Google Search behavior changes (AI-driven) hitting referred traffic. Not cyclical; a persistent headwind. NaukriGulf slowdown: Growth fell to 12% from prior ~20% due to geopolitical disruptions; margins 35%, profitable but momentum slowed.

The bull-bear ledger

What works, what doesn't
  • Billings growth 14–15% on a soft hiring market—solid execution

  • 99acres inflection: 89% loss reduction; path to cash-generativity credible

  • Jobseeker segment accelerating (35% billings, 2.6% paid conversion)—new monetization leg

  • Market leadership entrenched (118M resume database, 69% iOS share in real estate)

  • Cash from operations +25% to ₹225 Cr; zero debt; ₹5,034 Cr cash balance

  • Reported profit inflated ₹156 Cr (32%) by portfolio MTM; adjusted growth is mid-teens, not exceptional

  • Volume growth stalled; consultant +1%, mid-market soft—structural hiring weakness

  • QoQ PAT down 35% despite YoY strength; adjusted for Q4 accounting, modest sequential improvement

  • AI-Rex only 1 cycle post-launch; 10% trial-to-paid conversion, renewals unproven; Naukri RMS precedent

  • Shiksha structural decline (-23% billings) from Google Search behavior changes; persistent headwind

  • FIIs reducing (down 4.25pp QoQ to 23.72%); domestic buying offsetting, but foreign trim is caution signal

Risks, ranked by concern to a holder

What could derail the thesis, in order of impact

Volume growth slowdown / macro hiring weakness

High

Management's stated 'real challenge.' Consultant +1% signals insourcing; mid-market soft; hiring market 'very modest.' If hiring doesn't accelerate, billings growth will compress and margin expansion will stall.

Portfolio income volatility masks core performance

High

₹156 Cr of reported PAT from portfolio MTM. Downside revaluation will hurt reported earnings and may confuse investor base on core health. Standalone metrics are the truth, but reported PAT is what multiples follow.

AI-Rex retention & cannibalization

Medium

Only 400 of 4k free trials converted (10%); one post-launch cycle. Renewal rate unproven. Naukri RMS showed early traction then faded. If renewal <80%, product viability is in doubt.

99acres cash-generativity path uncertain

Medium

Path to 25–30% EBITDA margins requires 18–20%+ billings growth and competitive relief post-Housing.com/Aurum consolidation. If growth stalls or competition resurges, timeline slips.

Shiksha structural decline / Google dependency

High

-23% billings in Q1 due to Google AI Search changes. Structural, not cyclical. If Google behavior persists or accelerates, Shiksha faces worse headwinds.

Valuation near ATH with FII trimming

Medium

Stock ₹1,357.3, only 3.6% below ATH ₹1,408.2. RSI 76.3 (overbought). FIIs down 4.25pp; domestic buying offsetting. If growth disappoints, multiple contraction is risk.

How the street is positioned

The result was announced Monday, 10 August, prior close ₹1,282. Day 1 reaction: +6.08% (delivery 48.6%—tight execution). By day 3 it was still +5.87%, suggesting the pop held. But ownership tells a mixed story. FII holdings fell 4.25pp QoQ to 23.72%, the lowest level in over a year (32.99% in Q1 FY26). Domestic institutions (DII) picked up 3.74pp to 27.82%, so Indian flows are absorbing the foreign exit. Promoters are steady at 37.47%. Volume is increasing, confirming interest, but the FII trim is telling. It suggests the overseas investor base is selectively reducing exposure near the highs, even as the domestic buyer supports the price. This is classic: domestic conviction (India hiring, real estate structural growth) fighting foreign caution (valuation, global rate sensitivity, growth deceleration). The stock sits 49% above its 52-week low and 3.6% below its all-time high, with overbought technicals (RSI 76.3). Mean reversion risk if next quarter's volume growth stays soft.

The debate

What to watch next

Catalysts to resolve the debate
  • 1 · Q2 AI-Rex adoption and renewal cycle

    400 customers Q1 end; ~300 in July; target 'several thousand' by year-end. 10% trial-to-paid is reasonable; the critical metric is renewal rate in Q2–Q3. If >80%, product is real. If <60%, it's trial-driven, not platform shift.

  • 2 · 99acres cash-generativity milestone

    On track for H2 FY27. Path requires 18–20%+ billings growth. If Q2–Q3 billings decelerate below 15%, timeline slips.

  • 3 · Underlying hiring volume recovery

    JobSpeak showed ~5% aggregate hiring; InfoEdge billings 14–15%. Gap is pricing/premiumization. If JobSpeak doesn't move toward 8–10% by H2, volume remains the constraint and billings growth will compress unless pricing power persists.

The number to track from here

Not reported PAT. Portfolio mark-to-market will swing; focus on standalone operating profit and cash from operations. Q1: ₹334 Cr operating profit, ₹225 Cr CFO (+25% YoY). If Q2 delivers ₹320–330 Cr operating profit and >₹200 Cr CFO, the core business is steady. If operating profit dips below ₹300 Cr or CFO falls <₹180 Cr, volume weakness has landed.

The verdict: a steady, well-run franchise facing near-term hiring volume headwinds. New products are real but early-stage. 99acres inflection is credible but margin expansion depends on growth hold. Valued fairly-to-rich near all-time high. The margin of safety is in standing pat and waiting for Q2 AI-Rex renewal rates and hiring sentiment to clarify. Rating: Hold. The bar to raise is (1) AI-Rex >80% renewal, (2) 99acres billings stay 18%+, (3) hiring volume inflection signals appear. The bar to cut is (1) AI-Rex retention <60%, (2) recruitment volume stalls, (3) 99acres growth falls below 15%.

Informational and educational content only. Not investment advice.

INFO EDGE (INDIA) LTD. (NAUKRI) Q1 FY27 Results, Transcript & Analysis — StockWatch